ceritinib and Pancreatic-Neoplasms

ceritinib has been researched along with Pancreatic-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for ceritinib and Pancreatic-Neoplasms

Article	Year
Antitumor activity and combined inhibitory effect of ceritinib with gemcitabine in pancreatic cancer. American journal of physiology. Gastrointestinal and liver physiology, 2020, 01-01, Volume: 318, Issue:1 Topics: Anaplastic Lymphoma Kinase; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Size; Deoxycytidine; Drug Resistance, Neoplasm; Extracellular Signal-Regulated MAP Kinases; Gemcitabine; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrimidines; Signal Transduction; STAT3 Transcription Factor; Sulfones; Xenograft Model Antitumor Assays	2020

Article

Year

Antitumor activity and combined inhibitory effect of ceritinib with gemcitabine in pancreatic cancer.

American journal of physiology. Gastrointestinal and liver physiology, 2020, 01-01, Volume: 318, Issue:1

Topics: Anaplastic Lymphoma Kinase; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Size; Deoxycytidine; Drug Resistance, Neoplasm; Extracellular Signal-Regulated MAP Kinases; Gemcitabine; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrimidines; Signal Transduction; STAT3 Transcription Factor; Sulfones; Xenograft Model Antitumor Assays

2020